Document is current

Any future updates will be listed below

Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement

Crossref DOI link: https://doi.org/10.1007/s11239-022-02677-7

Published Online: 2022-07-13

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark